Zai Lab Limited P/E Ratio

Zai Lab Limited (ZLAB) currently reports a P/E ratio of -13.01. That is below the Healthcare sector average of 77.98. Use the charts on this page to explore Zai Lab Limited's P/E ratio history and peer comparisons.

Zai Lab Limited's P/E ratio of -13.01 is lower than the Healthcare sector average of 77.98. That is roughly 116.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Zai Lab Limited's market price to a fundamental measure such as earnings, sales, or book value. At -13.01, ZLAB can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -13.01, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 77.98. From there, open related valuation or income-statement pages for Zai Lab Limited, and consider following ZLAB for alerts when major investors trade the stock.

Zai Lab Limited is classified in the Healthcare sector. On P/E ratio, it currently shows -13.01 versus a sector average near 77.98. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZLAB with unrelated industries.